Abstract: A method and apparatus for establishing an access channel in a wireless communication system is provided, comprising receiving an AccessGrant on a carrier on which the last probe was transmitted and ending an access probe transmission upon receiving the AccessGrant. A method and apparatus is further provided, comprising determining expiration of an access grant timer and ending an access probe transmission upon the expiration of the timer. A method and apparatus is further provided comprising receiving an IdleState.IdleHO indication and ending an access probe transmission upon receiving the IdleState.IdleHO indication. A method and apparatus is further provided receiving a new AttemptAccess command, wherein the AttemptAccess command is processed after a current probe transmission ends and ending an access probe transmission on receiving the new AttemptAccess command.
Abstract: A device for at least one of diagnosis and treatment of binocular vision disorders is disclosed. The device comprises a portable, wearable viewing apparatus that includes a left eye electronic display and a right eye electronic display, a dual data channel input, wherein each data channel corresponds to a respective one of the left eye and right eye electronic displays, a left eye adjustable optic structure adjusting a view of the left eye electronic display, and a right eye adjustable optic structure adjusting a view of the right eye electronic display.
Type:
Grant
Filed:
September 20, 2010
Date of Patent:
December 11, 2012
Assignee:
Hong Kong Applied Science and Technology Research Institute Co., Ltd.
Abstract: This invention is based on the experimental finding that HIP/PAP has mitogenic and antiapoptotic effects in vitro on hepatocytes in primary culture. Moreover, HIP/PAP is a mitogenic and anti-apoptotic molecule for hepatocytcs, in vivo, during liver failure and liver regeneration. The present invention is also based on the experimental finding that HIP/PAP administration has no adverse effects in mammals. This invention concerns a pharmaceutical composition for stimulating liver regeneration in vivo including after chronic/acute liver failure, comprising an effective amount of a polypeptide comprising an amino acid sequence having 90% amino acid identity with the polypeptide consisting of the amino acid sequence starting at the amino acid residue (36) and ending at the amino acid residue (175) of sequence SEQ ID No 1, in combination with at least one physiologically acceptable excipient.
Type:
Grant
Filed:
February 22, 2011
Date of Patent:
December 11, 2012
Assignees:
Instiut National de la Santéet de la Recherche Médicale (INSERM), Universite Rene Descartes
Inventors:
Laurence Christa, Christian Brechot, Marie-Thérèse Simon-Gage-Soufflot, Alain Pauloin, J. Guilherme Tralhao
Abstract: Block copolymers labelled with molecular recognition units and comprising a hydrophobic block and a luminescent block are presented. A method of detecting biomolecules using such block copolymers is also presented. More specifically, the block copolymers of the present invention have the following Formula (I): wherein “A” is a hydrophobic block; “B” is a luminescent block; “C” is a hydrophilic block; “D” is a molecular recognition unit; “n” and “m” are integers ranging from 1 to 75; “x” is either 0 or an integer ranging from 1 to 75; and “Y” is either 0 or 1.
Type:
Grant
Filed:
May 26, 2006
Date of Patent:
December 4, 2012
Assignee:
McGill University
Inventors:
Hanadi Sleiman, Bingzhi Chen, Kim Metera
Abstract: A method for establishing a multi-carrier HSDPA channel and method for transmitting multi-carrier downlink packet data are provided. The method for establishing a multi-carrier HSDPA channel includes: A. determining number of HSDPA channel resources of a cell; B. selecting N carriers in the cell according to the number of channel resources determined in step A, wherein the N carriers form the HSDPA channel resources; C. allocating the HSDPA channel resources to be HS-DSCHs, uplink and downlink control channels; D. allocating, by a network, an HS-DSCH to be used by a user terminal, one or more HS-SCCHs and one or more mate HS-SICHs to be monitored by the user terminal, when the user terminal initiates an HSDPA request and the request is allowed. The method may be applied to multi-carrier downlink packet data transmission, to enhance peak transmission rate of user packets, optimize the resources, thereby improving system throughput.
Type:
Grant
Filed:
June 29, 2006
Date of Patent:
December 4, 2012
Assignee:
Shanghai Ultimate Power Communications Technology Co., Ltd.
Inventors:
Ying-min Wang, Guiliang Yang, Shaohui Sun
Abstract: The present invention concerns oxocarbonamide peptide nucleic acids (OxoPNAs). OxoPNAs provide increased stability, sensitivity, and specificity as compared to their natural DNA and RNA counterparts. The OxoPNA molecules of the present invention may be employed in a wide range of applications, particularly in applications involving hybridization. For example, OxoPNA probes may be employed for the detection and functional analysis of nucleic acid molecules, including miRNAs and other non-coding RNAs.
Abstract: A Fabry-Perot filter is applied as a thin coating on a film, for example, a packaging film, and permits interesting color effects. The coating has a layered construction in which both reflecting layers of the filter may be made of aluminum and the intermediate layer between the reflecting layers may be made of aluminum oxide.
Type:
Grant
Filed:
December 9, 2010
Date of Patent:
December 4, 2012
Assignee:
Applied Materials GmbH & Co. KG
Inventors:
Gerd Hoffmann, Rainer Ludwig, Hans-Georg Lotz, Gerhard Steiniger
Abstract: Disclosed is a method of treating a wound comprising applying a composition to a wound site on a patient in need of wound treatment, wherein the composition comprises mitotically inactive allogeneic cells that secrete one or more biologically active molecules selected from the group consisting of GM-CSF, VEGF, KGF, bFGF, TGF?, angiopoietin, EGF, IL-I?, IL-6 IL-8, TGF?, and TNF?, and wherein the cells are keratinocytes or fibroblasts, or mixtures thereof.
Type:
Grant
Filed:
February 8, 2012
Date of Patent:
December 4, 2012
Assignee:
DFB Technology Holdings, LLC
Inventors:
Eric Rolland, Thomas Hunziker, Beatrice Mis, Christopher Rinsch
Abstract: The present invention provides methods to produce toxoid vaccines, such as ricin A chain vaccines, with reduced ability to promote vascular leak syndrome (VLS) and catalytic toxicity associated with various proteinaceous toxins, such as ribosome inactivating proteins. The invention also provides toxoids which have been mutated to lack amino acid sequences which induce VLS and toxic catalytic activity.
Type:
Grant
Filed:
February 12, 2007
Date of Patent:
December 4, 2012
Assignee:
The Board of Regents of the University of Texas System
Inventors:
Ellen S. Vitetta, Victor F. Ghetie, Joan E. Smallshaw, Roxana G. Baluna
Abstract: The present invention relates to a method for optimizing power/ground pads in a power/ground distribution network. A power/ground distribution network is created for each of multiple voltage domains and a load current source of each node of the power/ground distribution network is modeled in consideration of the actual shapes and areas of functional blocks. A local optimization method is developed to solve problems generated when a conventional optimization method is applied to optimization of power/ground pads in a bump shape used for a flip chip, and a combination of global optimization and local optimization is applied to layouts using bump bonding, which is discriminated from the conventional optimization method restrictively applicable to layouts using wire bonding.
Abstract: A method and apparatus for updating configuration attributes by transmitting a FastRepage Attribute in a wireless communication system is provided, comprising generating a FastRepage Attribute comprising an 8 bit Length field wherein the Length field indicates a value of length of the FastRepage attribute in octets excluding the length of Length field, an 8 bit AttributeID field, an 8 bit FastRepageEnabled field wherein the FastRepageEnabled field is set to a value ‘0x01’ to indicate that FastRepage is enabled and a 16 bit FastRepageInterval field, wherein the FastRepageInterval field indicates a value of interval at which an access network pages an access terminal when the access network does not receive a response to a page and transmitting the FastRepage attribute over a communication link. A method and apparatus is further provided for receiving and processing the FastRepage attribute.
Type:
Grant
Filed:
October 27, 2006
Date of Patent:
December 4, 2012
Assignee:
Qualcomm Incorporated
Inventors:
Rajat Prakash, Fatih Ulupinar, Gavin Horn
Abstract: Systems and methods which provide a versatile lighting module which may be utilized alone or in combination with other lighting modules to provide any number of lighting unit configurations are shown. Lighting modules of embodiments herein are adapted to facilitate electrical connection, whether to one or more power supply and/or to one or more other lighting module, along any portion of the entire periphery of the lighting module. Accordingly, lighting modules may be coupled together in any orientation, geometry, and topology to cooperate as a light source having various desired characteristics according to embodiments herein.
Type:
Grant
Filed:
August 8, 2011
Date of Patent:
December 4, 2012
Assignee:
XtraLight Manufacturing Partnership Ltd
Inventors:
Jerry H. Caroom, Jr., Ken McAlpin, Luis E. Anker, Jason H. Lynch
Abstract: A kit and a method are provided for easily measuring the concentration of an active ingredient of a termite insecticide persisting in soil, particularly on site where a termite insecticide was actually applied. A kit of the present invention comprises 1) an extraction unit for extracting, with an solvent, a termite insecticide active ingredient from an object of measurement and 2) a reaction unit including a reaction container for encapsulating an identifying antigen, a fixing member for immobilizing an antibody against an active ingredient, and a sealing member capable of fitting to the reaction container. The kit optionally includes 3) a detection unit for visually or optically detecting a change depending on the concentrations of the active ingredient in the object of measurement, and 4) a dilution unit for diluting the sample solution to a certain ratio.
Abstract: The present invention relates to systems and methods for a multi-cell deployment model of a wireless backhaul network that implements frequency reuse. The backhaul network includes a plurality of cells, each of which includes a center hub supporting wireless backhaul communication over four geographic sectors. A first tier of the plurality of cells includes a center cell configured to support a first alternating frequency reuse pattern of a first channel and a second channel over four corresponding geographic sectors. A second tier of the plurality of cells surrounds the first tier. The second tier includes a first cell configured to support the first alternating reuse pattern over four corresponding geographic sectors, and wherein the first cell is horizontally adjacent to the center cell.
Type:
Grant
Filed:
November 19, 2010
Date of Patent:
December 4, 2012
Assignee:
Taqua WBH, LLC
Inventors:
Seyed Mohammad Ali Arad, Frank van Heeswyk
Abstract: Azelaic acid or its derivatives or analogs induce a robust and a speedier defense response against pathogens in plants. Azelaic acid treatment alone does not induce many of the known defense-related genes but activates a plant's defense signaling upon pathogen exposure.
Type:
Grant
Filed:
August 14, 2008
Date of Patent:
November 27, 2012
Assignees:
The University of Chicago, UT-Battelle, LLC
Inventors:
Jean T. Greenberg, Ho Won Jung, Timothy Tschaplinski
Abstract: The present invention relates to methods and systems for labeling, isolating, detecting, and/or enumerating a statistically significant number of biological cells, or other biological analytes of interest, present in a complex matrix sample. The isolation of a biological target of interest from a sample mixture is done by immunomagnetic separation. Upon introduction of the sample within an imaging chamber, the capture complex (biological target-magnetic capture agent) will be attracted by the magnetic field and will lay on the surface of the chamber in the focal plane of the imaging system.
Type:
Grant
Filed:
January 7, 2009
Date of Patent:
November 27, 2012
Assignee:
Luminex Corporation
Inventors:
Bruce J-C Bernard, Kurt D. Hoffacker, Charles J. Collins
Abstract: A preferred embodiment of the present invention comprises a mobile cantilever transfer device for transferring mobility-impaired patients. In one embodiment, the mobile cantilever transfer device includes a support surface that is cantilevered from a lift cart so that the support surface may be positioned over the origination or destination location for a transfer, such as a patient's bed. In yet another embodiment, the cantilevered support surface may be laterally extended from the lift cart in order to allow the support surface to be positioned at different points over a transfer location without moving the lift cart. In yet another embodiment, multiple sides of the support surface may be connected to the lift cart so that a transfer can be accomplished from multiple directions, such as on either side of a patient's bed.